Latest Prostate-specific antigen Stories
Very small sample-size study incapable of showing cause-and-effect relationship WASHINGTON, March 3, 2014 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) offers
New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb.
Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan.
Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated.
LOS ANGELES, Jan.
A new study reveals that in the prediction of treatment outcome for castration-resistant prostate cancer, a change in circulating tumor cells detection might be more accurate than the change in prostate-specific antigen levels.